Study: Therapy reduces proptosis, diplopia in TED.
| Published in: | Ophthalmology Times Vol. 44; no. 20; pp. 1 - 3 |
|---|---|
| Main Authors: | , , |
| Format: | pictorial Journal Article |
| Published: |
MJH Life Sciences
Dec2019
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=140328551&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 140328551 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 0193032X OTI jtl: Ophthalmology Times issn: 0193032X maglogo: N pubinfo: dt: Dec2019 vid: 44 iid: 20 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 140328551 140328551 140328551 140328551 ppf: 1 ppct: 2 formats: fmt: @attributes: type: P tig: atl: Study: Therapy reduces proptosis, diplopia in TED. aug: au: Charters, Lynda Douglas, Raymond S. Wester, Sara T. affil: Consultant, Horizon Therapeutics sug: subj: Exophthalmos Diplopia Graves' Ophthalmopathy Drug Therapy Antibodies, Monoclonal Therapeutic Use Research, Medical pubtype: Trade Publication doctype: pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|